Clinical Trials Insight: 700013481
Latest Information Update: 20 Jun 2006
At a glance
- Drugs FAV 201 (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Adverse reactions
- Sponsors MMRGlobal
- 20 Jun 2006 New trial record.
Latest Information Update: 20 Jun 2006